MANAGEMENT OF RESISTANT HYPERTENSION AND IMPLICATIONS OF PATHWAY-2 TRIAL IN US CARDIOLOGY PRACTICE: INSIGHTS FROM THE NCDR PINNACLE REGISTRY
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32292-7
Abstract: Patients with resistant hypertension (rHTN) have uncontrolled hypertension despite receiving at least 3 anti-HTN medication classes. The recent PATHWAY-2 Trial demonstrated superior HTN control when spironolactone was added as a 4th agent in rHTN. However,… read more here.
Keywords: management resistant; cardiology; resistant hypertension; hypertension ... See more keywords